Reviews and feature articleGenetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies
Section snippets
Epidemiology
With the expansion of EoE cases reported worldwide, multiple studies have aimed to establish a baseline prevalence of EoE and determine whether disease incidence has increased. From 2000-2003, the estimated prevalence of EoE in a pediatric population was approximately 4 in 10,000, with an incidence rate of 0.9 to 1.3 in 10,000 new cases per year.5 A similar prevalence (approximately 2 cases per 10,000) and incidence rate (1.4 per 100,000) during a 16-year period were observed in an adult Swiss
Genetic heritability
An underlying genetic predisposition to EoE has been proposed by multiple groups that show a disproportionate prevalence of disease in white subjects and male subjects and within families of affected subjects.15, 23 For instance, data over a 14-year period demonstrated that 90% of the patients with EoE were white and 75% were male.15 Reports of a familial occurrence of EoE and esophageal dilatation in 6.8% and 9.7% of patients with EoE, respectively, suggest that the prevalence of EoE and
Transcriptome analysis
A major step toward the molecular mapping of EoE was achieved when gene expression profiling of patients’ esophageal biopsy specimens showed a remarkable transcript signature that distinguishes patients with EoE from healthy control subjects and patients with chronic esophagitis.27 Altered expression of approximately 574 genes comprises this EoE “transcriptome,” which exhibits a high level of conservation among patients’ sex, age, and atopic history and strongly correlates with esophageal
Genetic variants and disease susceptibility
The number of studies investigating genetic variants associated with EoE are few compared with those for other more common and more widely recognized atopic diseases, such as AD and asthma. Regardless, there have been significant strides in uncovering EoE risk variants in a relatively short period of time14, 27, 52, 53 due in part to the technological advances in genotyping single nucleotide polymorphisms (SNPs) in large case-control cohorts. In all, there have been 4 candidate gene studies
Conclusions and future directions
In just over 10 years since the recognition of EoE as a distinct inflammatory disorder, the rapid progress toward characterizing the disease on multiple fronts has underscored its complexity. We now have insight into the natural history of EoE, its strong association with specific ethnicities and sexes, the genetic and environmental factors involved, and the molecular pathogenesis of the disease (Fig 1). Moreover, the burst of data illustrating EoE risk variants in CCL26, TGFB1, TSLP and CRLF2,
References (81)
Granuloma of the esophagogastric junction with eosinophilic infiltration
Gastroenterology
(1962)- et al.
Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment
Gastroenterology
(2007) - et al.
Pediatric patients with eosinophilic esophagitis: an 8-year follow-up
J Allergy Clin Immunol
(2007) - et al.
Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease
Clin Gastroenterol Hepatol
(2009) - et al.
Involvement of mast cells in eosinophilic esophagitis
J Allergy Clin Immunol
(2010) - et al.
The natural history of peanut allergy
J Allergy Clin Immunol
(2001) - et al.
Eosinophilic esophagitis: escalating epidemiology?
J Allergy Clin Immunol
(2005) - et al.
Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999
J Allergy Clin Immunol
(2010) - et al.
A case-control study of sociodemographic and geographic characteristics of 335 children with eosinophilic esophagitis
Clin Gastroenterol Hepatol
(2009) - et al.
Asthma in the inner city: the perspective of the National Institute of Allergy and Infectious Diseases
J Allergy Clin Immunol
(2010)
Eosinophilic esophagitis: pathogenesis, genetics, and therapy
J Allergy Clin Immunol
Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases
Clin Gastroenterol Hepatol
IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids
J Allergy Clin Immunol
Human epidermal differentiation complex in a single 2.5 Mbp long continuum of overlapping DNA cloned in bacteria integrating physical and transcript maps
J Invest Dermatol
Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations
J Allergy Clin Immunol
Filaggrin in atopic dermatitis
J Allergy Clin Immunol
Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses
Mucosal Immunol
Esophageal remodeling in pediatric eosinophilic esophagitis
J Allergy Clin Immunol
Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase
J Biol Chem
Analysis of the polymorphisms in eotaxin gene family and their association with asthma, IgE, and eosinophil
Biochem Biophys Res Commun
TGFB1 promoter polymorphism C-509T and pathophysiology of asthma
J Allergy Clin Immunol
The role of thymic stromal lymphopoietin (TSLP) in allergic disorders
Curr Opin Immunol
T lymphocyte activation gene identification by coregulated expression on DNA microarrays
Genomics
Environmental epigenetics of asthma: an update
J Allergy Clin Immunol
Epigenetic regulation of the IL-13-induced human eotaxin-3 gene by CBP-mediated histone 3 acetylation
J Biol Chem
Eosinophilic esophagitis: updated consensus recommendations for children and adults
J Allergy Clin Immunol
Eosinophilic esophagitis
N Engl J Med
Eosinophilic esophagitis
Curr Opin Pediatr
Eosinophilic esophagitis: the newest esophageal inflammatory disease
Nat Rev Gastroenterol Hepatol
Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis
Gut
Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis
Am J Gastroenterol
Increased number of regulatory T cells in children with eosinophilic esophagitis
J Pediatr Gastroenterol Nutr
Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction
J Allergy Clin Immunol
Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids
Allergy
14 years of eosinophilic esophagitis: clinical features and prognosis
J Pediatr Gastroenterol Nutr
Food allergy and eosinophilic esophagitis
Curr Opin Allergy Clin Immunol
The link between allergies and eosinophilic esophagitis: implications for management strategies
Expert Rev Clin Immunol
Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study
Gut
Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States
J Pediatr Gastroenterol Nutr
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis
J Clin Invest
Cited by (111)
Microbiota profiling in esophageal diseases: Novel insights into molecular staining and clinical outcomes
2024, Computational and Structural Biotechnology JournalEpidemiologic and Clinical Clues to the Etiology of Eosinophilic Esophagitis
2024, Immunology and Allergy Clinics of North AmericaEosinophilic esophagitis
2024, Dysphagia: A Clinical GuideThe Role of the Environment in Eosinophilic Esophagitis
2021, Journal of Allergy and Clinical Immunology: In PracticeAssociation of eosinophil-mediated inflammatory biomarkers with the presence of the Schatzki ring
2021, Advances in Medical Sciences
Series editors: Joshua A. Boyce, MD, Fred Finkelman, MD, William T. Shearer, MD, PhD, and Donata Vercelli, MD
Supported in part by National Institutes of Health (NIH) grants 2U19 AI066738, U19 AI070235, R01 DK076893, and R37 AI1045898; PHS Grant P30 DK078392; the Department of Defense; the Food Allergy Project; the Buckeye Foundation; and the Campaign Urging Research for Eosinophilic Disease (CURED) Foundation. J.D.S. is supported by a T32 NIH training grant (HL091805).
Terms in boldface and italics are defined in the glossary on page 24.